Table 4

Organ at risk objectives 

Organ at riskObjectives
Central biliary tractLess than 0.5 cc ≥70 Gy
(NRG-GI001 - http://www.cancer.gov/clinicaltrials)
VBED1040<37 cc and VBED1030<45 cc31
HeartMax dose <57 Gy
(RTOG 1112 - http://www.cancer.gov/clinicaltrials)
GallbladderMax dose <86.7 Gy
(RTOG 1112- http://www.cancer.gov/clinicaltrials)
Skin (external contour)Less than 0.5 cc ≥50.25 Gy
(RTOG 1112 - http://www.cancer.gov/clinicaltrials)
  • RTOG, Radiation Therapy Oncology Group.